$LMND News

Lemonade, Inc. 2026 Q2 - Results - Earnings Call Presentation

Lemonade: Growth Is Working, But The Insurance Economics Still Are Not

Keefe, Bruyette & Woods Upgrades Lemonade (LMND)

Piper Sandler Maintains Neutral on Lemonade, Lowers Price Target to $51

Keefe, Bruyette & Woods Upgrades Lemonade to Market Perform, Maintains Price Target to $48

Lemonade, Inc. (LMND) Q2 2026 Earnings Call Transcript

Lemonade Boosts Forecast Amid Premium Growth Momentum

Lemonade: Favorable Reinsurance Shift And Pushing Toward Profits

Lemonade Appoints Nick Stead As CFO

Lemonade Sees Q3 Sales $323.000M-$326.000M vs $320.445M Est

Lemonade Raises FY2026 Sales Guidance from $1.197B-$1.203B to $1.214B-$1.220B vs $1.207B Est

Piper Sandler Maintains Neutral on Lemonade, Raises Price Target to $75

Morgan Stanley Downgrades Lemonade (LMND)

Keefe, Bruyette & Woods Maintains Underperform on Lemonade, Raises Price Target to $48

Morgan Stanley Downgrades Lemonade to Equal-Weight, Maintains Price Target to $75

Why Is Lemonade Stock Surging On Monday?

Lemonade Renews Reinsurance Program, Effective July 1

Lemonade (LMND) Price Target Increased by 11.16% to 67.78

Lemonade, Inc. (LMND) Presents at Morgan Stanley US Financials Conference 2026 Transcript

Lemonade: Hard To Turn Down At $4.5B Market Cap